Keywords: Melanoma treatments, Yervoy, Zelboraf, Roche, Bristol-Myers Squibb, Decision Resources

Yervoy and Zelboraf rapidly penetrating metastatic patient population in USA and Europe

Article | 23 August 2012

Print This

In the USA and Europe there is strong physician desire for new therapies for the treatment of early stage melanoma, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in